GlassScriptPhysician profile
Marty Clark
NPI 1093473142
$1,254.85
in general payments reported to CMS, 2019-2025
20 companies · $480 in 2025
The $480 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $66.31 · 2023: $191 · 2024: $517 · 2025: $480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,188.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $193.20 | 2024-2025 | |
| Medtronic, INC. | $165.58 | 2024 | Ellipsys Vascular Access System, Venaseal |
| Bard Peripheral Vascular, INC. | $142.95 | 2024-2025 | Fluency Endovascular Stent Graft, Covera, Venclose Maven Catheter |
| Boston Scientific Corporation | $134.63 | 2025 | Accolade Sr |
| E.R. Squibb & Sons, L.L.C. | $109.06 | 2024-2025 | Eliquis, Camzyos |
| Janssen Pharmaceuticals, INC | $80.65 | 2023-2024 | Xarelto |
| Stryker Corporation | $63.34 | 2025 | Venacore Thrombectomy Catheter, Clottriever Bold Catheter |
| W. L. Gore & Associates, INC. | $54.74 | 2023-2025 | Gore Viabahn Endoprosthesis With Heparin, Gore Viabahn Vbx Balloon Expandable Endo |
| Abbott Laboratories | $50.61 | 2023-2025 | Diamondback Peripheral, Freestyle Libre 3 |
| Inari Medical, INC. | $36.61 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cardiovascular Systems INC. | $34.07 | 2022-2023 | Diamondback Peripheral |
| Endologix LLC | $28.80 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.31 | 2023-2025 | |
| Solventum Corporation | $24.23 | 2024 | Activ.A.C., Prevena, V.A.C. Veraflo |
| Cordis US Corp. | $23.45 | 2023 | Saber |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $21.38 | 2024 | Trintellix |
| Smith+Nephew, INC. | $19.20 | 2022 | |
| Kci USA, INC. | $17.76 | 2023 | Promogran Prisma, 3m Coban, Kerramax Care |
| Exact Sciences Corporation | $13.67 | 2023 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.61 | 2025 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marty Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.